Division of Cardiac, Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Institute of Pathology, Hannover Medical School, Hannover, Germany.
Am J Transplant. 2019 Feb;19(2):345-355. doi: 10.1111/ajt.15075. Epub 2018 Sep 12.
Ex vivo lung perfusion (EVLP) has become routine practice in lung transplantation. Still, running periods exceeding 12 hours have not been undertaken clinically to date, and it remains unclear how the perfusion solution for extended running periods should be composed and which parameters may predict outcomes. Twenty-four porcine lungs underwent EVLP for 24 hours using the Organ Care System (OCS). Lungs were ventilated and perfused with STEEN's solution enriched with erythrocytes (n = 8), acellular STEEN's solution (n = 8), or low-potassium dextran (LPD) solution enriched with erythrocytes (n = 8). After 24 hours, the left lungs were transplanted into recipient pigs. After clamping of the contralateral lung, the recipients were observed for 6 hours. The most favorable outcome was observed in organs utilizing STEEN solution enriched with erythrocytes as perfusate, whereas the least favorable outcome was seen with LPD solution enriched with erythrocytes for perfusion. Animals surviving the observation period showed lower peak airway pressure (PAWP) and pulmonary vascular resistance (PVR) during OCS preservation. The results suggest that transplantation of lungs following 24 hours of EVLP is feasible but dependent on the composition of the perfusate. PAWP and PVR during EVLP are early and late predictors of transplant outcome, respectively.
体外肺灌注 (EVLP) 已成为肺移植的常规实践。尽管如此,迄今为止,临床上还没有进行超过 12 小时的运行周期,并且仍不清楚延长运行周期的灌注液应该如何组成,以及哪些参数可以预测结果。24 个猪肺使用 Organ Care System (OCS) 进行了 24 小时的 EVLP。肺通过 STEEN 溶液(富含红细胞)(n=8)、无细胞 STEEN 溶液(n=8)或富含红细胞的低钾右旋糖酐(LPD)溶液进行通气和灌注。24 小时后,将左肺移植到受体猪中。在对侧肺夹闭后,观察受体 6 小时。结果表明,使用富含红细胞的 STEEN 溶液作为灌注液的器官观察到的结果最有利,而使用富含红细胞的 LPD 溶液灌注的结果最不利。在观察期幸存下来的动物在 OCS 保存期间显示出较低的峰值气道压 (PAWP) 和肺血管阻力 (PVR)。结果表明,在 EVLP 后 24 小时进行肺移植是可行的,但取决于灌注液的成分。EVLP 期间的 PAWP 和 PVR 分别是移植结果的早期和晚期预测指标。